5-Chloro-3-iodo-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazolo[4,3-b]pyridine, 98%, 100mg

3-(Trifluoromethyl)-5,6,7,8-tetrahydro-1,6-naphthyridine dihydrochloride, 97%, 100mg

BUT-3-EN-1-AMINE HCL, 95.0%, 10g

(S)-2-Methyl-1-(4-(trifluoromethyl)phenyl)propan-1-amine hydrochloride, 95%, 1g

8-Fluoroquinolin-2(1H)-one, 95.0%, 5g

2-([1,1'-Biphenyl]-2-yloxy)ethyl Acrylate (stabilized with MEHQ)>90.0%(HPLC)25g

4-(2-Bromoethyl)benzoic acid, 95.0%, 5g

(S)-2-(2,4-Difluorophenyl)pyrrolidine hydrochloride, 95%, 250mg

methyl 3-oxo-3,4-dihydro-2H-1,4-benzoxazine-8-carboxylate, 95.0%, 5g

2,6-Dichloro-4-iodonicotinaldehyde, 97.0%, 5g

(R)-tert-Butyl 3-(3-nitropyridin-2-yloxy)pyrrolidine-1-carboxylate, 95.0%, 1g

Ethyl [(2-methoxyphenyl)carbamoyl]formate, 97%, 500mg

(3R,4R,5R)-3,4-Bis(benzyloxy)-5-((benzyloxy)methyl)dihydrofuran-2(3H)-one, 98%, 5g